» Articles » PMID: 8286103

ErbB-3, a Third Member of the ErbB/epidermal Growth Factor Receptor Gene Family: Its Expression in Head and Neck Cancer Cell Lines

Overview
Date 1993 Jan 1
PMID 8286103
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Proto-oncogenes encoding growth factor receptors constitute several distinct families with close overall structural homology. The highest degree of homology can be observed in their catalytic domains, which are essential for intrinsic tyrosine kinase activity. Growth factor receptors in several of these families play critical roles in the regulation of normal cell growth and development. Some of these molecules have been implicated in the neoplastic process as well. A related DNA fragment distinct from epidermal growth factor receptor and erbB-2 genes was detected by reduced stringency hybridization of v-erbB to normal genomic human DNA. The expression of erbB-3 was studied by southern and northern blot technique in a subset of nine head and neck tumor cell lines, as well as in three immortalized cultures established from normal human salivary glands. No gene amplification of erb-B-3 was noted in any of the head and neck cell lines. The 6.2 kb transcript of erbB-3 was elevated significantly in an epidermoid carcinoma of the larynx (A388) and an esophageal carcinoma (HA 114).

Citing Articles

Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.

Chang C, Shim J, Byeon S, Lee E, Lee Y, Kim T Cancers (Basel). 2022; 14(9).

PMID: 35565268 PMC: 9104480. DOI: 10.3390/cancers14092139.


Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma.

Almadori G, Coli A, De Corso E, Mele D, Settimi S, Di Cintio G J Transl Med. 2021; 19(1):408.

PMID: 34579737 PMC: 8477517. DOI: 10.1186/s12967-021-03081-0.


Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.

Vairaktaris E, Goutzanis L, Vassiliou S, Spyridonidou S, Nkenke E, Papageorgiou G J Cancer Res Clin Oncol. 2007; 134(3):337-44.

PMID: 17704947 DOI: 10.1007/s00432-007-0289-7.


c-erbB3 protein expression in ovarian cancer.

Rajkumar T, Stamp G, Hughes C, Gullick W Clin Mol Pathol. 1996; 49(4):M199-202.

PMID: 16696074 PMC: 408058. DOI: 10.1136/mp.49.4.m199.


Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

O-Charoenrat P, Rhys-Evans P, Court W, Box G, Eccles S Clin Exp Metastasis. 2000; 17(7):631-9.

PMID: 10845563 DOI: 10.1023/a:1006751016860.

References
1.
Saranath D, Panchal R, Nair R, Mehta A, Sanghavi V, Sumegi J . Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res. 1989; 80(5):430-7. PMC: 5917753. DOI: 10.1111/j.1349-7006.1989.tb02332.x. View

2.
Cowley G, Smith J, Gusterson B . Increased EGF receptors on human squamous carcinoma cell lines. Br J Cancer. 1986; 53(2):223-9. PMC: 2001344. DOI: 10.1038/bjc.1986.39. View

3.
Yokota J, Yamamoto T, Toyoshima K, Terada M, Sugimura T, Battifora H . Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet. 1986; 1(8484):765-7. DOI: 10.1016/s0140-6736(86)91782-4. View

4.
Moore C . Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study. JAMA. 1971; 218(4):553-8. View

5.
Libermann T, Nusbaum H, Razon N, Kris R, Lax I, Soreq H . Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 1985; 313(5998):144-7. DOI: 10.1038/313144a0. View